-
Ex-Pakistan PM Khan taken back to jail after hospital checks: govt
-
'I'll adapt': First pregnant candidate navigates French presidential race
-
China, Indonesia hold talks on security, defence
-
Hong Kong convicts Tiananmen vigil activists of inciting subversion
-
Train to nowhere? South Korea's lonely push for peace with the North
-
The Hong Kong Tiananmen vigil activists convicted in national security trial
-
Australia's Hussey mulls role with England for Ashes series
-
Eel-powered Japan whizz-kid, 11, chases Asian Games history
-
Indian captain 'scapegoat' in Britain's Russia shadow fleet case, wife says
-
Asian markets extend rally as traders assess US Treasuries pledge
-
Rosenior seeks to match Paris FC's capital ambition as Ligue 1 returns
-
Barcelona enter new era as Flick targets La Liga hat-trick
-
Inter set for Serie A title defence as Milan get Amorim reboot
-
Pogacar favourite for Vuelta with Grand Tour treble in sight
-
'Greatest' Springboks face All Blacks in clash of juggernauts
-
Bangladesh coach Simmons wary of Australia backlash in second Test
-
William and Harry: Britain's warring royal brothers
-
Hong Kong Tiananmen activists to receive national security verdict
-
UN holds second informal poll for next leader
-
Who are the candidates vying to lead the UN?
-
In US mining hub, black lung rates soar
-
Swiatek into Cincinnati semis after Rybakina injury
-
Champions Arsenal embrace being 'hunted' as Premier League returns
-
University suspends academic behind Jason Arday plagiarism charges
-
World No.2 Rybakina retires from Cincinnati clash with Swiatek
-
Key European leaders demand Israel halt West Bank settlement project
-
'I heard you missed me': Melania Trump jokes about month out of spotlight
-
Kiwi Ears Stardust: The Art of Natural Balance
-
IRA-Eligible Gold: Rules, Approved Coins, and Best Gold Dealers (Guide Released)
-
McIlroy bounces back to share BMW Championship lead
-
Amazon Prime Video to invest $2 bn in Latin America productions
-
Cobolli fueled by candy in sweet defeat of Paul
-
Panama Canal to reduce shipping over El Nino-fueled drought
-
Jailed Pakistan ex-PM Khan moved to hospital on court order: party
-
Maradona trial on hold over possible medical evidence mix-up
-
Pogacar eyes 'missing' piece ahead of Vuelta return
-
'Green dilemma': China's solar boom hurt birds, says study
-
US, Canada 'very close' to trade deal, Ottawa says, as details emerge
-
Pegula hangs on to dispatch Anisimova, reach Cincinnati semi-finals
-
Ronaldinho returns in search of 'beautiful' 300th goal
-
US charges woman with IS-inspired plot to blow up New York State Capitol
-
US pushes allies, China to back Trump's economic war on Iran
-
What a record-breaking El Nino could mean for the world
-
Former NBA MVP Harden reportedly set to return to Cavaliers
-
Duplantis edges Karalis to win Lausanne Diamond League pole vault
-
Brook makes Pakistan pay for drop as England dominate first Test
-
Alcaraz to return for US Open title defence
-
MemeCore Arrives on Nasdaq Through $1 Billion Landmark Treasury Transaction
-
China's rapid solar expansion hurt bird diversity: study
-
First US deportees land in Liberia
Medical Care Technologies (OTCID:MDCE) Launches StrainScan Pro - Expanding AI Vision Platform into High-Value Agricultural & Food Quality Control Markets
New AI-Powered Platform Targets Multi-Trillion-Dollar Agriculture and Food Supply Chain Opportunities Through Advanced Visual Identification and Quality Monitoring
MESA, AZ / ACCESS Newswire / August 5, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced the public launch of StrainScan Pro, an AI-powered visual intelligence platform initially focused on cannabis strain identification and analysis for dispensaries, with broader applications in agricultural quality control, food distribution, restaurants, and grocery supply-chain monitoring.

StrainScan Pro leverages the Company's proprietary AI vision technology to deliver rapid, accurate visual analysis. While the platform launches with specialized capabilities for the cannabis retail sector, its underlying computer-vision architecture is designed for expansion into quality-control use cases across the wider agricultural and food industries.
The global agriculture market represents one of the largest economic sectors worldwide, with gross production value measured in the multi-trillion-dollar range. Parallel opportunities exist in food safety and quality control, where AI-driven visual inspection systems are experiencing rapid adoption as companies seek greater efficiency, consistency, and risk reduction across markets, distribution centers, restaurants, and processing facilities.
"StrainScan Pro represents another practical application of our AI vision technology," said Marshall Perkins, CEO of Medical Care Technologies. "We are focused on building tools that solve real identification and quality-monitoring challenges. The same core capabilities that power StrainScan Pro can be applied to agricultural produce grading, food quality inspection, and supply-chain verification - markets of enormous scale."
The launch of StrainScan Pro continues Medical Care Technologies' strategy of deploying its AI vision platform across multiple verticals while generating non-dilutive capital through subsidiaries such as Infinite Auctions and Real Game Used.
Investors and industry participants can explore the platform at: https://strainscanpro.com
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company also owns subsidiaries Infinite Auctions and Real Game Used, which provide complementary revenue-generating operations. Visit: https://medicalcaretechnologies.com
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.
Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221,
Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: [email protected]
Websites: https://medicalcaretechnologies.com | https://strainscanpro.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
R.Chavez--AT